Emma C. Thomson

MRC-University of Glasgow Centre for Virus Research

Glasgow

United Kingdom

Queen Elizabeth University Hospital

Glasgow, G51 4TF

United Kingdom

SCHOLARLY PAPERS

3

DOWNLOADS
Rank 434

SSRN RANKINGS

Top 434

in Total Papers Downloads

62,073

SSRN CITATIONS

4

CROSSREF CITATIONS

2

Scholarly Papers (3)

1.

Single Dose Administration, And The Influence Of The Timing Of The Booster Dose On Immunogenicity and Efficacy Of ChAdOx1 nCoV-19 (AZD1222) Vaccine

Number of pages: 37 Posted: 01 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Siena - Institute of Global Health, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, Federal University of Sao Paulo, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, University of the Witwatersrand, Soweto Clinical Trials Centre, Soweto Clinical Trials Centre, University of Oxford - Centre for Vaccinology and Tropical Medicine, Setshaba Research Centre, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of the Witwatersrand - South African Medical Research Council Vaccines and Infectious Diseases Analytical Research Unit, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Cape Town (UCT) - Centre for Lung Infection and Immunity, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - Oxford Vaccine Group, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, Wits Reproductive Health & HIV Institute (WRHI), University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University of Oxford - Oxford Vaccine Group, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Bristol - Cellular and Molecular Medicine, University of London - St George's Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - South African Medical Research Council, Liverpool School of Tropical Medicine - Department of Clinical Sciences, AstraZeneca Pharmaceuticals, University of the Witwatersrand - South African Medical Research Council, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of the Witwatersrand - South African Medical Research Council, University of the Witwatersrand - South African Medical Research Council, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Oxford - Centre for Vaccinology and Tropical Medicine, AstraZeneca Pharmaceuticals, Braziland Hospital São Rafael - Escola Bahiana de Medicina e Saúde Pública, Universidade Federal do Rio Grande do Norte (UFRN), University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of the Witwatersrand - Perinatal HIV Research Unit, Setshaba Research Centre, University of Oxford - Oxford Vaccine Group, Hospital Quinta D'OR, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, Hospital Universitário de Santa Maria, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Universidade Federal do Rio Grande do Sul, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, University of Cambridge - Department of Medicine, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine and Independent
Downloads 51,892 (31)
Citation 3

Abstract:

Loading...

2.

Efficacy of ChAdOx1 nCoV-19 (AZD1222) Vaccine Against SARS-CoV-2 VOC 202012/01 (B.1.1.7)

Number of pages: 40 Posted: 04 Feb 2021
University of Oxford - Oxford Vaccine Group, University of Oxford - Big Data Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Cambridge, University of Oxford - Wellcome Centre for Human Genetics, University of Oxford - The Jenner Institute, Public Health England - National Infection Service, University of Oxford - Centre for Vaccinology and Tropical Medicine, Liverpool School of Tropical Medicine - Department of Clinical Sciences, UK Biocentre, University of Sheffield - Department of Infection, Immunity and Cardiovascular Disease, University of Oxford - Oxford Vaccine Group, University of Oxford - Jenner Institute, Newcastle upon Tyne Hospitals NHS Foundation Trust - Department of Infection and Tropical Medicine, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Southampton - NIHR Southampton Clinical Research Facility and Biomedical Research Centre, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - Oxford Vaccine Group, University of Bristol - Cellular and Molecular Medicine, University of Oxford - The Jenner Institute, University of Oxford - Jenner Institute, University of London - St George's Vaccine Institute, University College London - Department of Infection, University of Oxford - Clinical BioManufacturing Facility, University Hospitals Birmingham NHS Foundation Trust, University of Oxford - Oxford Vaccine Group, Public Health England - National Infection Service, University of London - Institute of Infection and Immunity, Queen Elizabeth University Hospital, Liverpool School of Tropical Medicine - Department of Clinical Sciences, University of Oxford - The Jenner Institute, University of Oxford - Centre for Vaccinology and Tropical Medicine, University Hospitals Bristol - University Hospitals Bristol and Weston NHS Foundation Trust, NIHR UCLH Clinical Research Facility, Hull University Teaching Hospitals NHS Trust, University of Cambridge, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - The Jenner Institute, London Northwest University Healthcare, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, NIHR Imperial Clinical Research Facility, University of Oxford - Oxford Vaccine Group, University of Glasgow - College of Medical, Veterinary & Life Sciences, University of Oxford - Centre for Vaccinology and Tropical Medicine, University of Oxford - Centre for Vaccinology and Tropical Medicine, Western General Hospital - Clinical Infection Research Group, MRC-University of Glasgow Centre for Virus Research, Royal Papworth HospitalUniversity of Cambridge - Heart and Lung Research Institute, Nottingham University Hospitals NHS Trust, AstraZeneca Biopharmaceuticals, AstraZeneca Pharmaceuticals, Anuerin Bevan University Health Board, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - The Jenner Institute, University of Oxford - Oxford Vaccine Group, University of Oxford - Oxford Vaccine Group, University of Oxford - Centre for Vaccinology and Tropical Medicine, Independent and Independent
Downloads 10,142 (707)
Citation 25

Abstract:

Loading...

3.

The Alpha Variant B.1.1.7 Was Not Associated With Excess Healthcare Acquired COVID-19 Infection in a Multi-Centre UK Hospital Study

Number of pages: 29 Posted: 28 Jul 2021
University College London, University College London - Department of Infection, Inflammation and Immunity, University College London - Institute for Global Health, University College London - Department of Infection, Inflammation and Immunity, King's College London - Centre for Clinical Infection and Diagnostics Research, University of Portsmouth, Advanced Pathogen Diagnostics Unit, University College London Hospitals NHS Foundation Trust, King's College London - Centre for Clinical Infection and Diagnostics Research, University of Glasgow - Medical Research Council (MRC), University College London - Division of Infection and Immunity, Government of the United Kingdom - Portsmouth Hospitals NHS Trust, Bart's Health NHS Trust - Division of Infection, Bart's Health NHS Trust - Division of Infection, Bart's Health NHS Trust - Division of Infection, St. George’s University of London - Institute for Infection and Immunity, University of Glasgow - Medical Research Council (MRC), University of Sheffield - Sheffield Biomedical Research Centre, University Hospitals NHS Foundation Trust - Southampton Specialist Virology Center, North West London Pathology - Department of Infection and Immunity, University College London - Department of Infection, Inflammation and Immunity, NHS Foundation Trust - Department of Microbiology, Government of the United Kingdom - Royal Free London NHS Foundation Trust, NHS Foundation Trust - Southampton Specialist Virology Centre, Government of the United Kingdom - Sheffield Teaching Hospitals, University College London - Department of Genetics & Genomic Medicine, Independent, Independent, University College London - Institute for Global Health, Bart's Health NHS Trust - Division of Infection, University College London - Institute for Clinical Trials and Methodology, Health Data Research UK, Imperial College London - Section of Adult Infectious Disease, University of Glasgow - Medical Research Council (MRC), Government of the United Kingdom - Royal Free London NHS Foundation Trust, King's College London - Centre for Clinical Infection and Diagnostics Research, University College London Hospitals NHS Foundation Trust - Advanced Pathogen Diagnostics Unit, Government of the United Kingdom - Sheffield Teaching Hospitals, St. George’s University of London - Institute of Infection & Immunity, Imperial College Healthcare NHS Trust, University of Portsmouth, University of Southampton - University Hospital Southampton NHS Foundation Trust, University College London Hospitals NHS Foundation Trust - Department of Clinical Virology, University of Sheffield - Department of Infection, Immunity & Cardiovascular Disease, King's College London - Centre for Clinical Infection & Diagnostics Research, MRC-University of Glasgow Centre for Virus Research, St. George’s University of London - Institute of Infection & Immunity and University College London - Department of Infection, Inflammation and Immunity
Downloads 39 (571,443)

Abstract:

Loading...

COVID-19; transmissibility; nosocomial outbreaks; lineage B.1.1.7; Alpha variant; SARS-CoV-2; variants of concern